Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: The Hisayama Study

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Mukai, Naoko ^a   Yasuda, Miho ^a   Ninomiya, Toshiharu ^a   Hata, Jun ^a   Hirakawa, Yoichiro ^a   Ikeda, Fumie ^a   Fukuhara, Masayo ^a   Hotta, Taeko ^b   Koga, Masafumi ^c   Nakamura, Udai ^a   Kang, Dongchon ^b   Kitazono, Takanari ^a   Kiyohara, Yutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c Kawanishi City Hospital   (Japan)

Author keywords

1,5 anhydroglucitol; 2 hour postload glucose; Diagnostic criteria; Fasting plasma glucose; Glycated albumin; Hemoglobin A1c; Retinopathy

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CLINICAL DIABETIC RETINOPATHY DISEASE SEVERITY SCALE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE SEVERITY; EYE EXAMINATION; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; PHOTOGRAPHY; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RETINOPATHY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; GLYCEMIC INDEX; HUMANS; JAPAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS;

EID: 84896720984     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-45     Document Type: Article

References (55)

1. International Expert Committee International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334. 2699715, 19502545, International Expert Committee.
2. Gillett MJ. International expert committee report on the role of the A1C assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334. Clin Biochem Rev 2009, 30:197-200. 2791773, 20011212.
3. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):S62-S69. 2797383, 20042775, American Diabetes Association.
4. World Health Organization Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. 2011, World Health Organization.
5. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, Knowler WC. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994, 308:1323-1328. 10.1136/bmj.308.6940.1323, 2540244, 8019217.
6. Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, Badran A, Sous ES, Ali MA. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 1997, 20:785-791. 10.2337/diacare.20.5.785, 9135943.
7. The Expert Committee on the diagnosis and classification of diabetes mellitus Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197. The Expert Committee on the diagnosis and classification of diabetes mellitus.
8. Pang C, Jia L, Jiang S, Liu W, Hou X, Zuo Y, Gu H, Bao Y, Wu Q, Xiang K, Gao X, Jia W. Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diabetes Metab Res Rev 2012, 28:276-283. 10.1002/dmrr.1307, 22139892.
9. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
10. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
11. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010, 376:419-430. 10.1016/S0140-6736(10)60576-4, 20594588.
12. Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P, Klein R, Klein BE, Zimmet P, Shaw J. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008, 371:736-743. 10.1016/S0140-6736(08)60343-8, 2350208, 18313502.
13. Massin P, Lange C, Tichet J, Vol S, Erginay A, Cailleau M, Eschwège E, Balkau B. Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol 2011, 129:188-195. 10.1001/archophthalmol.2010.353, 3317887, 21320965.
14. Miyazaki M, Kubo M, Kiyohara Y, Okubo K, Nakamura H, Fujisawa K, Hata Y, Tokunaga S, Iida M, Nose Y, Ishibashi T. Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia 2004, 47:1411-1415.
15. Sabanayagam C, Liew G, Tai ES, Shankar A, Lim SC, Subramaniam T, Wong TY. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?. Diabetologia 2009, 52:1279-1289. 10.1007/s00125-009-1360-5, 19387611.
16. Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2011, 34:145-150. 10.2337/dc10-1206, 3005450, 20978099.
17. Xin Z, Yuan MX, Li HX, Hua L, Feng JP, Shi J, Zhu XR, Cao X, Yang JK. Evaluation for fasting and 2-hour glucose and HbA1c for diagnosing diabetes based on prevalence of retinopathy in a Chinese population. PLoS One 2012, 7:e40610. 10.1371/journal.pone.0040610, 3395674, 22808204.
18. Ito C. Evidence for diabetes mellitus criteria in 2010 using HbA1c. Diabetol Int 2013, 4:9-15.
19. Selvin E, Francis LM, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL, Steffes MW. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care 2011, 34:960-967. 10.2337/dc10-1945, 3064058, 21335368.
20. Kim WJ, Park CY, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Kim SW, Park HS, Kim YJ, Song SJ, Ahn HY. Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in type 2 diabetes. Diabet Med 2012, 29:1184-1190. 10.1111/j.1464-5491.2012.03613.x, 22332964.
21. Tominaga M, Makino H, Yoshino G, Kuwa K, Takei I, Aono Y, Hoshino T, Umemoto M, Shimatsu A, Sanke T, Kuwashima M, Taminato T, Ono J. Report of the committee on standardization of laboratory testing related to diabetes mellitus of the Japan Diabetes Society: determination of reference intervals of hemoglobin A1C (IFCC) and glycoalbumin in the Japanese population. J Japan Diab Soc 2006, 49:825-833. (in Japanese).
22. Ma XJ, Pan JM, Bao YQ, Zhou J, Tang JL, Li Q, Xiang KS, Jia WP. Combined assessment of glycated albumin and fasting plasma glucose improves the detection of diabetes in Chinese subjects. Clin Exp Pharmacol Physiol 2010, 37:974-979. 10.1111/j.1440-1681.2010.05417.x, 20557319.
23. Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia 2011, 54:3028-3036. 10.1007/s00125-011-2310-6, 21947435.
24. Yamanouchi T, Akanuma Y, Toyota T, Kuzuya T, Kawai T, Kawazu S, Yoshioka S, Kanazawa Y, Ohta M, Baba S, Kosaka K. Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus. Diabetes 1991, 40:52-57. 10.2337/diab.40.1.52, 2015974.
25. Robertson DA, Alberti KG, Dowse GK, Zimmet P, Tuomilehto J, Gareeboo H. Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening?. Diabet Med 1993, 10:56-60. 10.1111/j.1464-5491.1993.tb01997.x, 8435989.
26. Goto M, Yamamoto-Honda R, Shimbo T, Goto A, Terauchi Y, Kanazawa Y, Noda M. Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests. Endocr J 2011, 58:13-17. 10.1507/endocrj.K10E-224, 21084770.
27. Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010, 57:751-762. 10.1507/endocrj.K10E-138, 20724796.
28. Kim WJ, Park CY. 1,5-anhydroglucitol in diabetes mellitus. Endocrine 2013, 43:33-40. 10.1007/s12020-012-9760-6, 22847316.
29. Ito C, Maeda R, Ishida S, Harada H, Inoue N, Sasaki H. Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract 2000, 49:181-186. 10.1016/S0168-8227(00)00156-X, 10963830.
30. Fukuhara M, Arima H, Ninomiya T, Hata J, Hirakawa Y, Doi Y, Yonemoto K, Mukai N, Nagata M, Ikeda F, Matsumura K, Kitazono T, Kiyohara Y. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama Study. Stroke 2013, 44:1512-1517. 10.1161/STROKEAHA.111.000704, 23640825.
31. Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, Fukuhara M, Ikeda F, Shikata K, Yoshida D, Yonemoto K, Kamouchi M, Kitazono T, Kiyohara Y. Secular trends in cardiovascular disease and its risk factors in Japanese: half century data from the Hisayama Study, 1961-2009. Circulation 2013, 128:1198-1205.
32. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S, 9686693.
33. Committee on the standardization of diabetes mellitus-related laboratory testing of Japan Diabetes Society International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012, 3:39-40. Committee on the standardization of diabetes mellitus-related laboratory testing of Japan Diabetes Society.
34. World Health Organization Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. 2011, Geneva: World Health Organization, World Health Organization.
35. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992. 10.1053/j.ajkd.2008.12.034, 19339088.
36. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266. National Kidney Foundation.
37. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682. 10.1016/S0161-6420(03)00475-5, 13129861.
38. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
39. Likhari T, Gama R. Glycaemia-independent ethnic differences in HbA1c in subjects with impaired glucose tolerance. Diabet Med 2009, 26:1068-1069. 10.1111/j.1464-5491.2009.02803.x, 19900241.
40. Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract 2010, 87:415-421. 10.1016/j.diabres.2009.12.013, 20061043.
41. Morita K, Saruwatari J, Miyagawa H, Uchiyashiki Y, Oniki K, Sakata M, Kajiwara A, Yoshida A, Jinnouchi H, Nakagawa K. Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus. Cardiovasc Diabetol 2013, 12:132. 10.1186/1475-2840-12-132, 3847457, 24028448.
42. Waugh NR, Shyangdan D, Taylor-Phillips S, Suri G, Hall B. Screening for type 2 diabetes: a short report for the National Screening Committee. Health Technol Assess 2013, 17:1-90.
43. Kramer CK, Araneta MR, Barrett-Connor E. A1C and diabetes diagnosis: the Rancho Bernardo study. Diabetes Care 2010, 33:101-103. 10.2337/dc09-1366, 2797952, 19837792.
44. Hjellestad ID, Astor MC, Nilsen RM, Søfteland E, Jonung T. HbA1c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients. Cardiovasc Diabetol 2013, 12:79. 10.1186/1475-2840-12-79, 3679936, 23705980.
45. Penno G, Solini A, Zoppini G, Orsi E, Fondelli C, Zerbini G, Morano S, Cavalot F, Lamacchia O, Trevisan R, Vedovato M, Pugliese G. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian multicenter study. Cardiovasc Diabetol 2013, 12:98. 10.1186/1475-2840-12-98, 3750360, 23829205.
46. Ikeda F, Doi Y, Ninomiya T, Hirakawa Y, Mukai N, Hata J, Shikata K, Yoshida D, Matsumoto T, Kitazono T, Kiyohara Y. Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama study. Cardiovasc Diabetol 2013, 12:164. 10.1186/1475-2840-12-164, 24195452.
47. Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y. Fasting plasma glucose cutoff for diagnosis of diabetes in a Japanese population. J Clin Endocrinol Metab 2008, 93:3425-3429. 10.1210/jc.2007-2819, 18559920.
48. Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 2008, 9:315-327. 10.1007/s11154-008-9090-4, 18654858.
49. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687. 10.1001/jama.295.14.1681, 16609090.
50. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008, 57:1349-1354. 10.2337/db08-0063, 18299315.
51. Shiraiwa T, Kaneto H, Miyatsuka T, Kato K, Yamamoto K, Kawashima A, Kanda T, Suzuki M, Imano E, Matsuhisa M, Hori M, Yamasaki Y. Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients. Diabetes Care 2005, 28:2806-2807. 10.2337/diacare.28.11.2806, 16249562.
52. Kilpatrick ES, Keevilt BG, Richmond KL, Newland P, Addison GM. Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose. Diabet Med 1999, 16:496-499. 10.1046/j.1464-5491.1999.00093.x, 10391398.
53. Nowatzke W, Sarno MJ, Birch NC, Stickle DF, Eden T, Cole TG. Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark™) and determination of reference intervals on the Hitachi 917 analyzer. Clin Chim Acta 2004, 350:201-209. 10.1016/j.cccn.2004.08.013, 15530479.
54. Nathan DM, Steffes MW, Sun W, Rynders GP, Lachin JM. Determining stability of stored samples retrospectively: the validation of glycated albumin. Clin Chem 2011, 57:286-290. 10.1373/clinchem.2010.150250, 21030684.
55. Harano T. Hemoglobinopathy in Japan: detection and analysis. Rinsho Byori 1999, 47:215-223. (in Japanese).